| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.7000H |
| P356 | DOI | 10.1073/PNAS.0600363103 |
| P932 | PMC publication ID | 1444883 |
| P698 | PubMed publication ID | 16632604 |
| P5875 | ResearchGate publication ID | 7147411 |
| P50 | author | Adriano Boasso | Q55188047 |
| Jakob Nilsson | Q55207977 | ||
| P2093 | author name string | Matthew J Dolan | |
| Jan Andersson | |||
| Michael J Kruhlak | |||
| Michel Dy | |||
| Jean-Philippe Herbeuval | |||
| Gene M Shearer | |||
| Andrew W Hardy | |||
| Stephanie A Anderson | |||
| P2860 | cites work | High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR | Q22242246 |
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 | ||
| Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. | Q33784777 | ||
| Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells | Q34014711 | ||
| Probability binning comparison: a metric for quantitating univariate distribution differences | Q34095012 | ||
| HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration | Q34466203 | ||
| Role for plasmacytoid dendritic cells in anti-HIV innate immunity | Q34560971 | ||
| CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis | Q35847699 | ||
| Plasmacytoid dendritic cells in immunity | Q35953140 | ||
| Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. | Q36011366 | ||
| Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infecti | Q36380721 | ||
| Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy | Q36541079 | ||
| Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells | Q37730553 | ||
| Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. | Q38973017 | ||
| Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells | Q39616950 | ||
| In vivo analysis of Fas/FasL interactions in HIV-infected patients. | Q39811836 | ||
| Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction | Q40437839 | ||
| HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes | Q40578990 | ||
| Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study). | Q40964230 | ||
| Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection | Q41163422 | ||
| Natural interferon alpha/beta-producing cells link innate and adaptive immunity | Q41748252 | ||
| Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs | Q42944061 | ||
| Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice | Q42944373 | ||
| Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection | Q43986794 | ||
| Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection | Q45738778 | ||
| Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. | Q51993308 | ||
| The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy. | Q52016591 | ||
| TRAIL/Apo-2-ligand-induced apoptosis in human T cells. | Q54146049 | ||
| Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. | Q55244180 | ||
| Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV‐1 Infection | Q62091076 | ||
| Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis | Q73276141 | ||
| Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients | Q74330262 | ||
| T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy | Q77084768 | ||
| A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response | Q80542447 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 7000-7005 | |
| P577 | publication date | 2006-04-21 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients | |
| P478 | volume | 103 |
| Q36239431 | A randomized clinical trial of alternative stress management interventions in persons with HIV infection |
| Q27342233 | Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline |
| Q33366417 | Beneficial effect of TRAIL on HIV burden, without detectable immune consequences |
| Q27334176 | Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection |
| Q35606616 | Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation |
| Q34458060 | Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an explorat |
| Q35991137 | CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells. |
| Q39419661 | CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells |
| Q38067705 | Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers |
| Q33613674 | Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation |
| Q28731004 | Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction |
| Q36510689 | Chronic innate immune activation as a cause of HIV-1 immunopathogenesis |
| Q37073330 | Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing |
| Q33700312 | Contrasting roles for TLR ligands in HIV-1 pathogenesis |
| Q91910509 | Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment |
| Q34474320 | Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis |
| Q35752667 | DCs and NK cells: critical effectors in the immune response to HIV-1. |
| Q27010312 | Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle? |
| Q38114911 | Dendritic cell dysregulation during HIV-1 infection |
| Q34657557 | Dendritic cells in progression and pathology of HIV infection. |
| Q34766895 | Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo. |
| Q37209049 | Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression |
| Q37033383 | Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection |
| Q28082841 | Disease-promoting effects of type I interferons in viral, bacterial, and coinfections |
| Q38613681 | Effect of type-I interferon on retroviruses. |
| Q56994404 | Elite control of HIV infection: implications for vaccine design |
| Q37498946 | Following TRAIL's path in the immune system |
| Q26829456 | Foxo3a: an integrator of immune dysfunction during HIV infection |
| Q44134757 | HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. |
| Q92437362 | HIV elite control is associated with reduced TRAILshort expression |
| Q33413051 | HIV induces TRAIL sensitivity in hepatocytes |
| Q37000907 | HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells |
| Q35751070 | HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells |
| Q36141492 | HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha |
| Q37676228 | HIV-1 immunopathogenesis in humanized mouse models |
| Q36656715 | HIV-1 immunopathogenesis: how good interferon turns bad. |
| Q36376089 | HIV-1 increases TLR responses in human primary astrocytes. |
| Q33359564 | HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation |
| Q50130203 | Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis |
| Q27009024 | Host-pathogen interaction in HIV infection |
| Q35914497 | Human and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species |
| Q36540073 | Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. |
| Q38000415 | IFN-α and TRAIL: a double edge sword in HIV-1 disease? |
| Q41544565 | Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes. |
| Q37254491 | Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model |
| Q33992829 | Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? |
| Q30362489 | Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? |
| Q35120242 | Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway |
| Q36949540 | Immunology. An interferon paradox |
| Q33676532 | Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand. |
| Q40129526 | Increased TNF-alpha and sTNFR2 levels are associated with high-grade anal squamous intraepithelial lesions in HIV-positive patients with low CD4 level |
| Q42225763 | Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates with chronic immune activation |
| Q28079717 | Innate and Adaptive Immune Regulation During Chronic Viral Infections |
| Q33997880 | Innate immune recognition and activation during HIV infection |
| Q40088680 | Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon. |
| Q34145979 | Interferon-alpha administration enhances CD8+ T cell activation in HIV infection |
| Q26861003 | Interferon-alpha, immune activation and immune dysfunction in treated HIV infection |
| Q55153874 | Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure. |
| Q34598849 | Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers |
| Q35370381 | Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. |
| Q30912292 | Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease |
| Q42089377 | Marginal zone B-cells, a gatekeeper of innate immunity |
| Q34545417 | Mechanisms of HIV-associated lymphocyte apoptosis: 2010 |
| Q48281703 | Mechanisms regulating expansion of CD8+ T cells during HIV-1 infection |
| Q36434255 | Next-Generation mRNA Sequencing Reveals Pyroptosis-Induced CD4+ T Cell Death in Early Simian Immunodeficiency Virus-Infected Lymphoid Tissues |
| Q37408390 | PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes |
| Q33663298 | Pathogenic potential of interferon αβ in acute influenza infection |
| Q96304699 | Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection? |
| Q42121015 | Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection |
| Q33608661 | Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients |
| Q37019332 | Plasmacytoid dendritic cells in HIV infection |
| Q33805319 | Plasmacytoid dendritic cells in HIV infection: striking a delicate balance |
| Q34261832 | Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis |
| Q35215887 | Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice |
| Q38271917 | Potential implication of residual viremia in patients on effective antiretroviral therapy |
| Q33856394 | Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers |
| Q39630648 | Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription |
| Q38035344 | Recent advances targeting innate immunity-mediated therapies against HIV-1 infection. |
| Q33649753 | Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. |
| Q34627162 | Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype |
| Q47558114 | Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity. |
| Q35172090 | The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases |
| Q26995244 | The Curious Case of Type I IFN and MxA: Tipping the Immune Balance in AIDS |
| Q35814700 | The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist |
| Q27025707 | The enduring tale of T cells in HIV immunopathogenesis |
| Q36707747 | The innate antiviral response: new insights into a continuing story |
| Q33810779 | The macrophage in HIV-1 infection: from activation to deactivation? |
| Q37053199 | The role of cytokines in the pathogenesis and treatment of HIV infection |
| Q37942501 | The type I interferon response during viral infections: a "SWOT" analysis |
| Q37547157 | Therapeutic depletion of natural killer cells controls persistent infection. |
| Q27347804 | Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection |
| Q40050805 | Transcriptomic meta-analysis identifies gene expression characteristics in various samples of HIV-infected patients with nonprogressive disease |
| Q37686199 | Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques |
| Q47548056 | Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control |
| Q38181142 | Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1. |
| Q52342680 | Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. |
| Q35192786 | Type I interferon contributes to CD4+ T cell depletion induced by infection with HIV-1 in the human thymus |
| Q91841187 | Type I interferon in HIV treatment: from antiviral drug to therapeutic target |
| Q35018048 | Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection |
| Q36889683 | Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion |
| Q37168039 | Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages |
| Q28255842 | Type I interferons in infectious disease |
| Q36426325 | Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance |
| Q36625289 | Virus-encoded TLR ligands reveal divergent functional responses of mononuclear phagocytes in pathogenic simian immunodeficiency virus infection |
Search more.